Abstract:Purpose: Posterior capsular opacification (PCO) is a common long-term complication of modern cataract surgery. Remnant lens epithelial cells (LECs) undergo a myofibroblast transdifferentiation that is thought to be the initial step of PCO pathogenesis. The purpose of this study is to determine the effects of zebularine on transforming growth factor-beta (TGF beta)-induced, LEC-myofibroblast transdifferentiation.Methods: The expression levels of methyl CpG binding protein 2 (MeCP2) and alpha-smooth muscle actin (alpha-SMA) in human PCO membranes were evaluated by confocal microscopy. The role that MeCP2 played in TGF beta 2-induced alpha-SMA expression was analyzed by western blotting both before and after MeCP2 knockdown with MeCP2-specific siRNA. The effect of zebularine on MeCP2 expression was analyzed over time using a variety of dosages. The effect of zebularine on TGF beta 2-induced alpha-SMA expression was determined by western blot analysis.Results: MeCP2 and alpha-SMA co-localized in human PCO membranes. When MeCP2 was depleted, TGF beta 2 could not induce alpha-SMA expression. Zebularine decreased MeCP2 expression in lens epithelial cells in a time-and dose-dependent pattern and reversed TGF beta 2-induced alpha-SMA expression.Conclusions: MeCP2 plays an important role in TGF beta 2-induced alpha-SMA expression in lens epithelial cells. Zebularine could reverse the TGF beta 2-induced alpha-SMA expression by inhibiting MeCP2 expression. Therefore, zebularine could potentially prevent PCO formation.

Zebularine Suppresses Tgf-Beta-Induced Lens Epithelial Cell-Myofibroblast Transdifferentiation by Inhibiting Mecp2